Negen Capital reduced its stake in Accent Microcell from 1.62% to 1.21%, selling 99,500 shares.
A pharmaceutical manufacturer specializing in pharmaceutical excipients, Accent Microcell Ltd produces inactive substances used in drug formulation and delivery systems. Incorporated in 2012, the company serves pharmaceutical manufacturers across India and international markets. Its focused approach to excipient manufacturing positions it as a specialized ingredient supplier within the broader pharmaceutical manufacturing supply chain.
Mumbai-based led by Neil Bahal. Runs an event-driven, special-situations multi-cap strategy looking for mergers, demergers, open offers and restructurings.
